Search
Filter Results
Displaying 491–500 of 952 results
-
Jul 22, 2020
AGTC Planning Phase 2/3 Clinical Trial for XLRP Gene Therapy
The company is also expanding its Phase ½ trial for the emerging treatment
-
Jul 22, 2020
Accepting grant applications for advancing retinal degeneration treatments toward human studies
-
Jul 17, 2020
A Phase 3 trial for the treatment is planned
-
Bronze Partner - Janssen Pharmaceutical Companies
Bronze Partner - Janssen Pharmaceutical Companies
-
Gold Partner and Accessibility Underwriter - Spark Therapeutics
Gold Partner & Accessibility Underwriter Spark Therapeutics
-
National Chapter Vision Webinars
Bimonthly national Vision Webinars providing key information impacting our community.
-
Jul 7, 2020
Biogen Entering into Licensing Agreement with Mass Eye and Ear to Develop PRPF31 Gene Therapy
The goal of the partnership is to advance a PRPF31 gene therapy into a clinical trial